Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When did brilinta generic come out?Cost of valsartan 320 mg?Potassium chloride forecasts?How much is brilinta?How long has brilinta been on the market?
See the DrugPatentWatch profile for levemir
Current Prices and Availability Prices for Levemir (insulin detemir) can vary depending on location, dosage form, and pack size. According to DrugPatentWatch.com, a website that tracks pharmaceutical patents and pricing, the cost of Levemir can range from around $250 to over $500 per 10 mL vial, depending on the specific product and location. Factors Affecting Pricing Several factors can affect the cost of Levemir, including: * Manufacturer: Prices may differ between manufacturers, such as Novo Nordisk and other generic or biosimilar producers. * Pack size: Larger packs tend to be cheaper per unit than smaller ones. * Dosage form: Injectables like Levemir are typically more expensive than oral medications. * Prescription coverage: Insurance plans and government programs may help cover a portion of the cost. * Generic or biosimilar alternatives: Entering the market, biosimilars like Insulite (Insulin Detemir) and generic versions like Insulin Detemir Injection by various manufacturers can decrease prices. Discounts and Access Programs Patients and healthcare professionals may find discounts and access programs that can reduce the out-of-pocket cost of Levemir. Some options include: * Manufacturer discounts: Novo Nordisk and other manufacturers may offer discounts, patient assistance programs, or coupons. * Government programs: Medicaid, the Veterans Administration, and other government programs may provide coverage for eligible patients. * Non-profit organizations: Organizations like the pharmaceutical patient assistance programs or the National Diabetes Foundation may offer financial assistance and education. Generic and Biosimilar Options Levemir's patent is set to expire in 2028. Upon expiration or when biosimilars enter the market before patent expiry, the cost of Levemir may decrease or become more competitive due to generic or biosimilar alternatives. Sources: [1] DrugPatentWatch.com: Insulin Detemir (Levemir) [2] Novo Nordisk: Levemir (insulin detemir) product information
Other Questions About Levemir :